SCHEDULE 13G FOR FUSION PHARMACEUTICALS INC. BY JOHNSON & JOHNSON

Company

JOHNSON & JOHNSON

Filed

July 6, 2020

Accession Number

0000904454-20-000428

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →